Atlas Trials

A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154

Clinical trial NCT04972968 · TERMINATED

Trial details

NCT number
NCT04972968
Sponsor
AbbVie
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Polymyalgia Rheumatica
Start date
2021-09-09
Primary completion
2023-07-24
Enrollment
181

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.